Fanconi Anemia Complementation Group F C3469526
Part of the Fanconi anemia family affecting DNA repair. Causes bone marrow failure, congenital abnormalities, and increased tumor risk. Management involves regular blood monitoring and possible stem cell transplant.
Key facts at a glance
- ICD-10
- D61.03
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pancytopenia
Recurrent infections
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Café-au-lait spots
(hematologic)Limb malformations
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Hematopoietic Stem Cell Transplantation (HSCT)
Standard curative approach for end-stage bone marrow failure, with newer protocols showing improved outcomes using alternative donors and reduced-toxicity conditioning.
Supportive Antibiotic Prophylaxis
Continuous or intermittent antimicrobial prophylaxis to prevent bacterial infections in neutropenic patients, typically including penicillin derivatives and antivirals during high-risk periods.
Additional treatment options
Corrective Surgery for Limb Anomalies
Surgical reconstruction of thumb and radial ray abnormalities to improve hand function and upper extremity capabilities, typically performed in early childhood.
surgicalComprehensive Cancer Surveillance
Enhanced tumor surveillance including annual solid tumor screening and head/neck examination given elevated risk of head and neck squamous cell carcinoma in FA patients.
monitoringNutritional Support and Micronutrient Supplementation
Comprehensive nutritional assessment and supplementation including zinc, vitamin D, and folate support to address malabsorption and increased metabolic demands from chronic disease.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Fanconi Anemia Complementation Group F C3469526?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Fanconi Anemia Complementation Group F C3469526. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy